Heparin exerts anti-apoptotic effects on uterine explants by targeting the endocannabinoid system.

about

Heparin exerts anti-apoptotic effects on uterine explants by targeting the endocannabinoid system.

Item

http://www.wikidata.org/entity/Q40629585

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Heparin exerts anti-apoptotic ...... ng the endocannabinoid system.

@en

type

Item

label

Heparin exerts anti-apoptotic ...... ng the endocannabinoid system.

@en

prefLabel

Heparin exerts anti-apoptotic ...... ng the endocannabinoid system.

@en

P1476

Heparin exerts anti-apoptotic ...... ng the endocannabinoid system.

@en

P2093

Ana Inés Salazar

http://www.w3.org/2001/XMLSchema#string

Ana María Franchi

http://www.w3.org/2001/XMLSchema#string

Carlos Davio

http://www.w3.org/2001/XMLSchema#string

Claudia Vercelli

http://www.w3.org/2001/XMLSchema#string

Fernando Correa

http://www.w3.org/2001/XMLSchema#string

Victoria Schiariti

http://www.w3.org/2001/XMLSchema#string

P2860

The role of infection in miscarriage

Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage

Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure

Anandamide-induced cell death: dual effects in primary rat decidual cell cultures

Epidemiology and causes of preterm birth

Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation.

Intrauterine infection and prematurity.

Progesterone is essential for protecting against LPS-induced pregnancy loss. LIF as a potential mediator of the anti-inflammatory effect of progesterone.

P2888

s10495-016-1269-7

P304

965-976

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10495-016-1269-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27364950

http://www.w3.org/2001/XMLSchema#string

P921

endocannabinoid system